Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

Recruiting

Phase 1

Phase 2

Vitamin CSympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

Sponsor:

University of Kansas Medical Center

Code:

NCT04715022

Conditions

Hypertension

Cardiovascular Diseases

Eligibility Criteria

Sex: All

Age: 35 - 65

Healthy Volunteers: Not accepted

Interventions

Ascorbic acid solution (American Regent Laboratories Inc.)

Saline

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-02-16. This information was provided to ClinicalTrials.gov by University of Kansas Medical Center on 2025-06-08.